Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Transmucosal Drug Delivery Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Transmucosal Drug Delivery Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Passive Transdermal Drug Delivery
      • 1.3.3 Active Transdermal Drug Delivery
    • 1.4 Market Segment by Application
      • 1.4.1 Global Transmucosal Drug Delivery Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Clinic
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Transmucosal Drug Delivery Market Size
      • 2.1.1 Global Transmucosal Drug Delivery Revenue 2014-2025
      • 2.1.2 Global Transmucosal Drug Delivery Sales 2014-2025
    • 2.2 Transmucosal Drug Delivery Growth Rate by Regions
      • 2.2.1 Global Transmucosal Drug Delivery Sales by Regions 2014-2019
      • 2.2.2 Global Transmucosal Drug Delivery Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Transmucosal Drug Delivery Sales by Manufacturers
      • 3.1.1 Transmucosal Drug Delivery Sales by Manufacturers 2014-2019
      • 3.1.2 Transmucosal Drug Delivery Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Transmucosal Drug Delivery Revenue by Manufacturers (2014-2019)
      • 3.2.2 Transmucosal Drug Delivery Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Transmucosal Drug Delivery Market Concentration Ratio (CR5 and HHI)
    • 3.3 Transmucosal Drug Delivery Price by Manufacturers
    • 3.4 Key Manufacturers Transmucosal Drug Delivery Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Transmucosal Drug Delivery Market
    • 3.6 Key Manufacturers Transmucosal Drug Delivery Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Passive Transdermal Drug Delivery Sales and Revenue (2014-2019)
      • 4.1.2 Active Transdermal Drug Delivery Sales and Revenue (2014-2019)
    • 4.2 Global Transmucosal Drug Delivery Sales Market Share by Type
    • 4.3 Global Transmucosal Drug Delivery Revenue Market Share by Type
    • 4.4 Transmucosal Drug Delivery Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Transmucosal Drug Delivery Sales by Application

    6 United States

    • 6.1 United States Transmucosal Drug Delivery Breakdown Data by Company
    • 6.2 United States Transmucosal Drug Delivery Breakdown Data by Type
    • 6.3 United States Transmucosal Drug Delivery Breakdown Data by Application

    7 European Union

    • 7.1 European Union Transmucosal Drug Delivery Breakdown Data by Company
    • 7.2 European Union Transmucosal Drug Delivery Breakdown Data by Type
    • 7.3 European Union Transmucosal Drug Delivery Breakdown Data by Application

    8 China

    • 8.1 China Transmucosal Drug Delivery Breakdown Data by Company
    • 8.2 China Transmucosal Drug Delivery Breakdown Data by Type
    • 8.3 China Transmucosal Drug Delivery Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Transmucosal Drug Delivery Breakdown Data by Company
    • 9.2 Rest of World Transmucosal Drug Delivery Breakdown Data by Type
    • 9.3 Rest of World Transmucosal Drug Delivery Breakdown Data by Application
    • 9.4 Rest of World Transmucosal Drug Delivery Breakdown Data by Countries
      • 9.4.1 Rest of World Transmucosal Drug Delivery Sales by Countries
      • 9.4.2 Rest of World Transmucosal Drug Delivery Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 3M Pharmaceuticals
      • 10.1.1 3M Pharmaceuticals Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Transmucosal Drug Delivery
      • 10.1.4 Transmucosal Drug Delivery Product Introduction
      • 10.1.5 3M Pharmaceuticals Recent Development
    • 10.2 Acrux Limited
      • 10.2.1 Acrux Limited Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Transmucosal Drug Delivery
      • 10.2.4 Transmucosal Drug Delivery Product Introduction
      • 10.2.5 Acrux Limited Recent Development
    • 10.3 ALZA Corporation
      • 10.3.1 ALZA Corporation Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Transmucosal Drug Delivery
      • 10.3.4 Transmucosal Drug Delivery Product Introduction
      • 10.3.5 ALZA Corporation Recent Development
    • 10.4 Antares Pharma, Inc.
      • 10.4.1 Antares Pharma, Inc. Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Transmucosal Drug Delivery
      • 10.4.4 Transmucosal Drug Delivery Product Introduction
      • 10.4.5 Antares Pharma, Inc. Recent Development
    • 10.5 Apricus BioSciences, Inc
      • 10.5.1 Apricus BioSciences, Inc Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Transmucosal Drug Delivery
      • 10.5.4 Transmucosal Drug Delivery Product Introduction
      • 10.5.5 Apricus BioSciences, Inc Recent Development
    • 10.6 Aveva Drug Delivery Systems
      • 10.6.1 Aveva Drug Delivery Systems Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Transmucosal Drug Delivery
      • 10.6.4 Transmucosal Drug Delivery Product Introduction
      • 10.6.5 Aveva Drug Delivery Systems Recent Development
    • 10.7 Corium International, Inc
      • 10.7.1 Corium International, Inc Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Transmucosal Drug Delivery
      • 10.7.4 Transmucosal Drug Delivery Product Introduction
      • 10.7.5 Corium International, Inc Recent Development
    • 10.8 DURECT Corporation
      • 10.8.1 DURECT Corporation Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Transmucosal Drug Delivery
      • 10.8.4 Transmucosal Drug Delivery Product Introduction
      • 10.8.5 DURECT Corporation Recent Development
    • 10.9 Generex Biotechnology Corporation
      • 10.9.1 Generex Biotechnology Corporation Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Transmucosal Drug Delivery
      • 10.9.4 Transmucosal Drug Delivery Product Introduction
      • 10.9.5 Generex Biotechnology Corporation Recent Development
    • 10.10 Inovio Pharmaceuticals, Inc.
      • 10.10.1 Inovio Pharmaceuticals, Inc. Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Transmucosal Drug Delivery
      • 10.10.4 Transmucosal Drug Delivery Product Introduction
      • 10.10.5 Inovio Pharmaceuticals, Inc. Recent Development
    • 10.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
    • 10.12 MedPharm LTD
    • 10.13 Mylan, Inc.
    • 10.14 Nemaura Pharma Ltd
    • 10.15 Nitto Denko Corporation
    • 10.16 Noven Pharmaceuticals, Inc.
    • 10.17 Pantec Biosolutions AG
    • 10.18 Tapemark
    • 10.19 tesa Labtec GmbH
    • 10.20 TEVA Pharmaceutical Industries Ltd.
    • 10.21 Zosano Pharma

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Transmucosal Drug Delivery Sales Channels
      • 11.2.2 Transmucosal Drug Delivery Distributors
    • 11.3 Transmucosal Drug Delivery Customers

    12 Market Forecast

    • 12.1 Global Transmucosal Drug Delivery Sales and Revenue Forecast 2019-2025
    • 12.2 Global Transmucosal Drug Delivery Sales Forecast by Type
    • 12.3 Global Transmucosal Drug Delivery Sales Forecast by Application
    • 12.4 Transmucosal Drug Delivery Forecast by Regions
      • 12.4.1 Global Transmucosal Drug Delivery Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Transmucosal Drug Delivery Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Transmucosal Drug Delivery is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Transmucosal Drug Delivery.

      This report studies the global market size of Transmucosal Drug Delivery, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Transmucosal Drug Delivery sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      3M Pharmaceuticals
      Acrux Limited
      ALZA Corporation
      Antares Pharma, Inc.
      Apricus BioSciences, Inc
      Aveva Drug Delivery Systems
      Corium International, Inc
      DURECT Corporation
      Generex Biotechnology Corporation
      Inovio Pharmaceuticals, Inc.
      Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
      MedPharm LTD
      Mylan, Inc.
      Nemaura Pharma Ltd
      Nitto Denko Corporation
      Noven Pharmaceuticals, Inc.
      Pantec Biosolutions AG
      Tapemark
      tesa Labtec GmbH
      TEVA Pharmaceutical Industries Ltd.
      Zosano Pharma

      Market Segment by Product Type
      Passive Transdermal Drug Delivery
      Active Transdermal Drug Delivery

      Market Segment by Application
      Hospital
      Clinic
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Transmucosal Drug Delivery status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Transmucosal Drug Delivery manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Transmucosal Drug Delivery are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now